Temitayo A. Ogunleye, MD
Dermatology

Temitayo A. Ogunleye, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology University City
View 1 additional location
Penn Medicine Provider

About me

  • Professor of Clinical Dermatology

My education and training

  • University of Pennsylvania School of MedicineMedical School
  • Albert Einstein Medical CenterResidency
  • University of Michigan HealthResidency

Spoken languages

English
English

Reviews

Average Rating

1773 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
She is always very thorough
Anonymous
September 2026
I have other family making an appointment if available in the near future.
Anonymous
September 2026
She is very professional
Anonymous
September 2026
Overall, it was a great experience today.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ogunleye is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and conditions

Research

Publications

Gupta R, Giordano JA, Lange A, Ogunleye T, Subhadarshani S Clinical profile of adult patients with erythromelalgia , J Am Acad Dermatol, 03314-1(26): 2026,S0190-9622


Pasricha T I’m a doctor. Here’s why I wear sunblock indoors , Washington Post: 2026


Schell N, Alomary SA, Baker N, Chung J, Ogunleye T, Taylor SC ChatGPT Exhibits Reduced Sensitivity in Identifying Concern for Malignancy in Darker Skin Tones , J Drugs Dermatol, 25(7): 2026,e64-e65


Alomary SA, Baker NJ, Li AZ, Ogunleye T, Taylor SC Racial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study , J Drugs Dermatol, 25(7): 2026,e69-e70


Gupta R, Perry N, Desir N, Encarnacion I, Miles J, Taylor S, Oboite M, Ogunleye T Central Centrifugal Cicatricial Alopecia in Pediatric Patients: A Retrospective Analysis , J Am Acad Dermatol, S0190-9622(26): 2026,03080-X


Alomary SA, Baker NJ, Alkiswani H, Schell N, Ogunleye T, Taylor SC Racial Differences in Frontal Fibrosing Alopecia: A 10-Year Single-Center Retrospective Cohort Study , J Am Acad Dermatol, S0190-9622(26): 2026


Encarnacion IN, Desir N, Schell N, Mehta A, Ogunleye T, Taylor S Visit complexity differs between scarring and nonscarring alopecia: A 5-year DataDerm analysis , J Am Acad Dermatol, 94(6): 2026,1853-55


Baker NJ, Alomary SA, Ogunleye T, Taylor S Risk of Lab Abnormalities in Nonscarring Alopecia on Low Dose Oral Minoxidil: A Retrospective Cohort Study , J Cutan Med Surg: 2026


Baker NJ, Alomary SA, Ogunleye T, Taylor S Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study , J Cutan Med Surg: 2026


Alomary SA, Baker NJ, Ogunleye T, Taylor ST, Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System , JAAD Int, 25: 2026,92-94